Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Lidocaine Infusion in Thyroid Surgery Using Intraoperative Neurophysiological Monitoring
NCT06785987Phase 4Enrolling by invitation
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Feb 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in thyroid nodule and thyroid tumor (3 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Incidence of bucking and inadequate depth of anesthesia. Started Feb 2024; status: enrolling by invitation.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
thyroid nodulethyroid tumor
Beyond the preview
Go deeper on NCT06785987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06785987.